Moderna (MRNA) has had the highest return since November 7, 2025 by a large-cap US stock, returning 964.9%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 964.89% |
Sandisk (SNDK) | 300.66% |
Revolution Medicines (RVMD) | 215.94% |
Micron Technology (MU) | 195.17% |
Glaukos (GKOS) | 174.34% |
SharkNinja (SN) | 141.86% |
Lumentum (LITE) | 130.52% |
Dell Technologies (DELL) | 124.34% |
Kymera Therapeutics (KYMR) | 118.49% |
ASE Industrial Holding Co Ltd ADR (ASX) | 113.13% |
BrightSpring Health Services, Inc Common Stock (BTSG) | 105.86% |
Viatris (VTRS) | 104.32% |
Valero Energy (VLO) | 100.16% |
Charles River Laboratories (CRL) | 99.82% |
Okta (OKTA) | 98.16% |
Hewlett Packard Enterprise (HPE) | 95.86% |
Marathon Petroleum (MPC) | 95.24% |
Advanced Micro Devices (AMD) | 94.44% |
United Microelectronics (UMC) | 93.33% |
APA (APA) | 93.13% |
Roivant Sciences (ROIV) | 90.59% |
Centene (CNC) | 88.49% |
Millicom International Cellular (TIGO) | 87.92% |
Life Time (LTH) | 87.28% |
HF Sinclair (DINO) | 87.19% |
Large-cap stocks are treated as having a market cap of $10B+.